{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:57:26Z","timestamp":1774450646827,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007175","name":"Conseil National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jacig.2023.100169","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T11:39:16Z","timestamp":1694950756000},"page":"100169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A\u00a0decade-long retrospective analysis (2012-2021)"],"prefix":"10.1016","volume":"3","author":[{"given":"Joelle","family":"Dagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Antonios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Chollet-Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"de Chaisemartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Pallardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayat","family":"Azouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Irani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7425","key":"10.1016\/j.jacig.2023.100169_bib1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/bmj.327.7425.1222","article-title":"Joining the DoTS: new approach to classifying adverse drug reactions","volume":"327","author":"Aronson","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jacig.2023.100169_bib2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s40629-015-0052-6","article-title":"Guideline for the diagnosis of drug hypersensitivity reactions","volume":"24","author":"Brockow","year":"2015","journal-title":"Allergo J Int"},{"key":"10.1016\/j.jacig.2023.100169_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.emc.2021.09.001","article-title":"Drug hypersensitivity reactions","volume":"40","author":"Wilkerson","year":"2022","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.jacig.2023.100169_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4168\/aair.2016.8.4.383","article-title":"New allergic and hypersensitivity conditions section in the international classification of diseases\u201411","volume":"8","author":"Tanno","year":"2016","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jacig.2023.100169_bib5","series-title":"Drug hypersensitivity","first-page":"2","article-title":"Epidemiology and causes of drug hypersensitivity","author":"Demoly","year":"2007"},{"key":"10.1016\/j.jacig.2023.100169_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.iac.2004.03.012","article-title":"Immune mechanism of drug hypersensitivity","volume":"24","author":"Pichler","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jacig.2023.100169_bib7","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jacig.2023.100169_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/all.14962","article-title":"The important role of non-covalent drug\u2013protein interactions in drug hypersensitivity reactions","volume":"77","author":"Pichler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000453265","article-title":"Classification of drug hypersensitivity into allergic, p-i, and pseudo-allergic forms","volume":"171","author":"Pichler","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.all.0000173785.81024.33","article-title":"Epidemiology of hypersensitivity drug reactions","volume":"5","author":"Gomes","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.mcna.2010.04.003","article-title":"Drug hypersensitivity reactions: pathomechanism and clinical symptoms","volume":"94","author":"Pichler","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jacig.2023.100169_bib12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2021.02.013","article-title":"Mechanisms of human drug-induced anaphylaxis","volume":"147","author":"Bruhns","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000339690","article-title":"Non-allergic drug hypersensitivity reactions","volume":"159","author":"Farnam","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib15","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/cea.12193","article-title":"Advances in our understanding of drug hypersensitivity","volume":"43","author":"Brockow","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib16","first-page":"11","article-title":"An updated review of the diagnostic methods in delayed drug hypersensitivity","author":"Copaescu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacig.2023.100169_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mcna.2019.09.003","article-title":"Drug hypersensitivity reactions","volume":"104","author":"Dykewicz","year":"2020","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jacig.2023.100169_bib18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-med-050913-022745","article-title":"T cell\u2013mediated hypersensitivity reactions to drugs","volume":"66","author":"Pavlos","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jacig.2023.100169_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.13562","article-title":"EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity","volume":"74","author":"Brockow","year":"2019","journal-title":"Allergy"},{"issue":"6 pt 2","key":"10.1016\/j.jacig.2023.100169_bib20","doi-asserted-by":"crossref","first-page":"S637","DOI":"10.1067\/mai.2000.106156","article-title":"Understanding drug allergies","volume":"105","author":"Gruchalla","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein\u2013coupled receptor X2 on mast cell\u2013mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib22","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/ijms18061223","article-title":"Reclassifying anaphylaxis to neuromuscular blocking agents based on the presumed patho-mechanism: IgE-mediated, pharmacological adverse reaction or \u201cinnate hypersensitivity\u201d?","volume":"18","author":"Spoerl","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacig.2023.100169_bib23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.all.0000011031.16814.e0","article-title":"Epidemiology of drug allergy","volume":"1","author":"Demoly","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/ph4010069","article-title":"Drug induced hypersensitivity and the HLA complex","volume":"4","author":"Alfirevic","year":"2010","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.jacig.2023.100169_bib25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.iac.2014.03.002","article-title":"Drug allergy diagnosis","volume":"34","author":"Chiriac","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jacig.2023.100169_bib26","first-page":"15","article-title":"Testing for drug hypersensitivity syndromes","volume":"34","author":"Rive","year":"2013","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jacig.2023.100169_bib27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s40264-019-00825-2","article-title":"Mechanisms of severe cutaneous adverse reactions: recent advances","volume":"42","author":"Bell\u00f3n","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacig.2023.100169_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jcpt.12752","article-title":"Drug-induced hypersensitivity: a 5-year retrospective study in a hospital electronic health records database","volume":"44","author":"Mendes","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jacig.2023.100169_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaip.2018.11.023","article-title":"Drug hypersensitivity reactions documented in electronic health records within a large health system","volume":"7","author":"Wong","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"suppl\u00a02","key":"10.1016\/j.jacig.2023.100169_bib30","first-page":"45","article-title":"The epidemiology of drug allergy-related consultations in Spanish allergology services: Alergol\u00f3gica-2005","volume":"19","author":"Gamboa","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib31","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1365-2222.2004.02070.x","article-title":"Self-reported drug allergy in a general adult Portuguese population","volume":"34","author":"Gomes","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2133.2003.05584.x","article-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","volume":"149","author":"Fiszenson-Albala","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2023.100169_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.555666","article-title":"Drug allergy profile from a national drug allergy registry","volume":"11","author":"Al-Ahmad","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacig.2023.100169_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2500\/aap.2014.35.3791","article-title":"Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population","volume":"35","author":"Albin","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jacig.2023.100169_bib35","doi-asserted-by":"crossref","first-page":"S195","DOI":"10.1016\/j.jaci.2007.12.726","article-title":"Outpatient consultation in allergy\/immunology","volume":"121","author":"Dietrich","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib36","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1182\/blood.V92.7.2435","article-title":"Role of JAK3 in CD40-mediated signaling","volume":"92","author":"Jabara","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jacig.2023.100169_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.ejhg.5200574","article-title":"Familial Mediterranean fever in Lebanon: mutation spectrum, evidence for cases in Maronites, Greek Orthodoxes, Greek Catholics, Syriacs and Chiites and for an association between amyloidosis and M694V and M694I mutations","volume":"9","author":"Mansour","year":"2001","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jacig.2023.100169_bib38","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1136\/jmg.38.10.e36","article-title":"Autosomal recessive non-syndromic hearing loss in the Lebanese population: prevalence of the 30delG mutation and report of two novel mutations in the connexin 26 (GJB2) gene","volume":"38","author":"Mustapha","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.jacig.2023.100169_bib39","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1258\/096914106776179827","article-title":"Prevalence of G6PD deficiency and knowledge of diagnosis in a sample of previously unscreened Lebanese males: clinical implications","volume":"13","author":"Khneisser","year":"2006","journal-title":"J Med Screen"},{"key":"10.1016\/j.jacig.2023.100169_bib40","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1067\/mai.2002.122214","article-title":"Task force report: future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions","volume":"109","author":"Adkinson","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib41","first-page":"21","article-title":"Epidemiological study of cutaneous adverse drug reactions in Oman","volume":"23","author":"Al-Raaie","year":"2008","journal-title":"Oman Med J"},{"key":"10.1016\/j.jacig.2023.100169_bib42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.aller.2013.07.007","article-title":"Drug allergy in tertiary care in Turkey: results of a national survey. The ADAPT study: Adult Drug Allergy Perception in Turkey","volume":"42","author":"\u00c7elik","year":"2014","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jacig.2023.100169_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011582","article-title":"Prevalence triggers and clinical severity associated with anaphylaxis at a tertiary care facility in Saudi Arabia: a cross-sectional study","volume":"97","author":"Alkanhal","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacig.2023.100169_bib44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsps.2022.12.006","article-title":"Assessing the prevalence and characteristics of self-reported penicillin allergy in Saudi Arabian population: a nationwide cross-sectional study","volume":"31","author":"Alowais","year":"2022","journal-title":"Saudi Pharm J"},{"issue":"suppl\u00a02","key":"10.1016\/j.jacig.2023.100169_bib45","first-page":"2","article-title":"Methodological aspects and sample characteristics of the study","volume":"19","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib46","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","article-title":"Epidemiology and risk factors for drug allergy","volume":"71","author":"Thong","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jacig.2023.100169_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.anai.2018.11.014","article-title":"Drug allergy in children and adults: is it the double X chromosome?","volume":"122","author":"Eaddy Norton","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib48","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaip.2018.10.045","article-title":"Capturing drug-induced anaphylaxis through electronic health records: a step forward","volume":"7","author":"Castells","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100169_bib49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ACI.0000000000000568","article-title":"Gender differences in anaphylaxis","volume":"19","author":"Salvati","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib50","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.3390\/jcm11102811","article-title":"Drug-related hypersensitivity reactions leading to emergency department: original data and systematic review","volume":"11","author":"Pagani","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacig.2023.100169_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13223-018-0289-y","article-title":"Drug allergy","volume":"14","author":"Warrington","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib52","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11882-014-0476-y","article-title":"Penicillin and beta-lactam allergy: epidemiology and diagnosis","volume":"14","author":"Macy","year":"2014","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jacig.2023.100169_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2022.853587","article-title":"Management of beta-lactam antibiotics allergy: a real-life study","volume":"3","author":"Iuliano","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.mcna.2010.04.006","article-title":"The complex clinical picture of \u03b2-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams","volume":"94","author":"Torres","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jacig.2023.100169_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/all.13848","article-title":"The challenge of de-labeling penicillin allergy","volume":"75","author":"Stone","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib56","first-page":"363","article-title":"Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients","volume":"22","author":"Do\u00f1a","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00038-013-0493-y","article-title":"Assessment of self-medication in population buying antibiotics in pharmacies: a pilot study from Beirut and its suburbs","volume":"59","author":"Cheaito","year":"2014","journal-title":"Int J Public Health"},{"key":"10.1016\/j.jacig.2023.100169_bib58","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11096-020-01218-7","article-title":"Trends in the consumption of antibiotics in the Lebanese community between 2004 and 2016","volume":"43","author":"Lahoud","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jacig.2023.100169_bib59","article-title":"Evaluation of antibiotic prescription in the Lebanese community: a pilot study","volume":"5","author":"Saleh","year":"2015","journal-title":"Infect Ecol Epidemiol"},{"key":"10.1016\/j.jacig.2023.100169_bib60","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jaci.2009.11.032","article-title":"Clavulanic acid can be the component in amoxicillin\u2013clavulanic acid responsible for immediate hypersensitivity reactions","volume":"125","author":"Torres","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jiph.2009.09.004","article-title":"Self-medication with antibiotics in the ambulatory care setting within the Euro-Mediterranean region; results from the ARMed project","volume":"2","author":"Scicluna","year":"2009","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jacig.2023.100169_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jiph.2014.07.010","article-title":"Assessing the Lebanese population for their knowledge, attitudes and practices of antibiotic usage","volume":"8","author":"Mouhieddine","year":"2015","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jacig.2023.100169_bib63","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11882-021-00997-x","article-title":"Skin testing for penicillin allergy: a review of the literature","volume":"21","author":"Zembles","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jacig.2023.100169_bib64","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.jaip.2019.02.040","article-title":"Penicillin allergy evaluation: a prospective, multicenter, open-label evaluation of a comprehensive penicillin skin test kit","volume":"7","author":"Solensky","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100169_bib65","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.2174\/1381612822666160928142814","article-title":"Hypersensitivity reactions to non-steroidal anti-inflammatory drugs","volume":"22","author":"Dona","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jacig.2023.100169_bib66","first-page":"182","article-title":"Challenge-based clinical patterns of 223 Spanish patients with non-steroidal anti-inflammatory-drug-induced-reactions","volume":"17","author":"Quiralte","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib67","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1016\/j.jaip.2020.04.051","article-title":"Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones","volume":"8","author":"Do\u00f1a","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100169_bib68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/pharmacy7030097","article-title":"Quinolone allergy","volume":"7","author":"McGee","year":"2019","journal-title":"Pharmacy"},{"key":"10.1016\/j.jacig.2023.100169_bib69","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/01410768221144760","article-title":"Disastrous decline of the healthcare system in Lebanon","volume":"116","author":"Jawad","year":"2023","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jacig.2023.100169_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12097","article-title":"Allergic patients during the COVID-19 pandemic\u2014clinical practical considerations: an European Academy of Allergy and Clinical Immunology survey","volume":"12","author":"Alvaro-Lozano","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib72","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.jaip.2020.03.012","article-title":"COVID-19: pandemic contingency planning for the allergy and immunology clinic","volume":"8","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2023.100169_bib74","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/all.14061","article-title":"Recent developments and highlights in drug hypersensitivity","volume":"74","author":"Mayorga","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1159\/000507445","article-title":"Drug-induced anaphylaxis: an update on epidemiology and risk factors","volume":"181","author":"Regateiro","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib76","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.jacig.2023.100169_bib77","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029571","article-title":"Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders","volume":"101","author":"Markovi\u0107","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacig.2023.100169_bib78","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/jama.2021.1967","article-title":"Reports of anaphylaxis after receipt of mRNA COVID-19 vaccines in the US\u2014December 14, 2020\u2013January 18, 2021","volume":"325","author":"Shimabukuro","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jacig.2023.100169_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm7004e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine\u2014United States, December 21, 2020\u2013January 10, 2021","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacig.2023.100169_bib80","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine\u2014United States, December 14-23, 2020","volume":"70","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jacig.2023.100169_bib81","series-title":"Clinical dermatology","article-title":"Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, staphylococcal scalded skin syndrome","author":"Smith","year":"2017"},{"key":"10.1016\/j.jacig.2023.100169_bib82","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacig.2023.100169_bib83","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2023.100169_bib84","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-Study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jacig.2023.100169_bib85","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1080\/07853890.2021.1976818","article-title":"What do we know about perioperative hypersensitivity reactions and what can we do to improve perioperative safety?","volume":"53","author":"Kosciuczuk","year":"2021","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.jacig.2023.100169_bib86","doi-asserted-by":"crossref","DOI":"10.23937\/2377-4630\/1\/3\/1013","article-title":"Allergy to general anesthetics: evaluation of patients profile","volume":"1","author":"Irani","year":"2014","journal-title":"Int J Anesthetic Anesthesiol"},{"key":"10.1016\/j.jacig.2023.100169_bib87","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","article-title":"Anaphylaxis during anesthesia in France: an 8-year national survey","volume":"128","author":"Mertes","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib88","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/pai.12703","article-title":"The gaps in anaphylaxis diagnosis and management by French physicians","volume":"28","author":"Pouessel","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib89","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.bja.2020.08.024","article-title":"Epidemiology and outcome of patients admitted to intensive care after anaphylaxis in France: a retrospective multicentre study","volume":"125","author":"Guerci","year":"2020","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacig.2023.100169_bib90","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/0259-1162.108286","article-title":"Anaphylaxis during the perioperative period","volume":"6","author":"Mali","year":"2012","journal-title":"Anesth Essays Res"},{"key":"10.1016\/j.jacig.2023.100169_bib91","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/aas.12855","article-title":"Anaesthetic hypersensitivity reactions in France between 2011 and 2012: the 10th GERAP epidemiologic survey","volume":"61","author":"Tacquard","year":"2017","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jacig.2023.100169_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12948-018-0094-7","article-title":"Focus on the agents most frequently responsible for perioperative anaphylaxis","volume":"16","author":"Di Leo","year":"2018","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jacig.2023.100169_bib93","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jacig.2023.100169_bib94","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1345\/aph.1Q004","article-title":"Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults","volume":"45","author":"Warr","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacig.2023.100169_bib95","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1093\/ajhp\/58.24.2381","article-title":"Neuromuscular blockers in surgery and intensive care, part 2","volume":"58","author":"McManus","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jacig.2023.100169_bib96","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00002018-200427060-00004","article-title":"Prevention of anaphylactic reactions to anaesthetic drugs","volume":"27","author":"Fisher","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacig.2023.100169_bib97","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ACO.0b013e3282ff85e1","article-title":"What investigation after an anaphylactic reaction during anaesthesia?","volume":"21","author":"Dewachter","year":"2008","journal-title":"Curr Opin Anesthesiol"},{"key":"10.1016\/j.jacig.2023.100169_bib98","first-page":"143","article-title":"Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity","volume":"24","author":"Do\u00f1a","year":"2014","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib99","doi-asserted-by":"crossref","first-page":"216","DOI":"10.18176\/jiaci.0236","article-title":"Practical guidelines for perioperative hypersensitivity reactions","volume":"28","author":"Laguna","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2023.100169_bib100","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/j.bja.2019.03.001","article-title":"Assessing cross-reactivity to neuromuscular blocking agents by skin and basophil activation tests in patients with neuromuscular blocking agent anaphylaxis","volume":"123","author":"Li","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacig.2023.100169_bib101","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/bja\/aes506","article-title":"Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011","volume":"110","author":"Sadleir","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jacig.2023.100169_bib102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12630-022-02375-1","article-title":"Anaphylaxis to neuromuscular blocking agents: cross-reactivity between rocuronium and cisatracurium","volume":"70","author":"Molero D\u00edez","year":"2023","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jacig.2023.100169_bib103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/15360288.2019.1666955","article-title":"Clinical manifestations and diagnostic evaluation of opioid allergy labels\u2014a review","volume":"33","author":"Kalangara","year":"2019","journal-title":"J Pain Palliat Care Pharmacother"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829323000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:21:32Z","timestamp":1762647692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829323000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2772829323000942"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100169","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A\u00a0decade-long retrospective analysis (2012-2021)","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2023.100169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100169"}}